TMEM-175

N/A

Report date: 2025/01/26 16:15:01
NME

Base Information

Drug NameTMEM-175
Drug Alias NameTMEM175 modulators (Caraway Therapeutics)TMEM-175
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndosomal/lysosomal potassium channel TMEM175 modulators
TargetsEndosomal/lysosomal potassium channel TMEM175
Therapy Area/IndicationsNerve DegenerationParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCaraway Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co IncAbbvie Inc
Inactive CompaniesCaraway Therapeutics Inc
Active IndicationsParkinson Disease
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A